Hiatal hernia repair using OviTex reinforced tissue matrix

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, open-label, multicenter, non-randomized post-market study enrolling up to 173 adults in the United States. Eligible patients undergoing elective robotic or laparoscopic primary hiatal hernia repair will receive reinforcement with OviTex Core Resorbable or OviTex 1S Resorbable. Subjects will be followed clinically with patient questionnaires and clinic visits through five years, and outcomes at 24 months will be compared to a literature control. The study will track hernia recurrence and post-operative complications after minimally invasive repair with OviTex reinforcement.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patient is a candidate for an elective robotic or laparoscopic primary hiatal hernia repair with the use of OviTex Core Resorbable or OviTex 1S Resorbable.
2. Patient is willing and able to voluntarily sign the IRB-approved Informed Consent Form for the study.
3. Patient is at least 22 years old at the time of surgery.
4. Patient is not pregnant and not planning to become pregnant during the duration of the study (5 years).
5. Patient is able and willing to comply with the study requirements including completion of patient questionnaires and clinic evaluations.

Exclusion Criteria (Baseline):

1. Patient has a Body Mass Index (BMI) of ≥ 35.
2. Patient meets the Centers for Disease Control (CDC) Surgical Site Infection (SSI) Wound Classification Class IV (Dirty-Infected) criteria.
3. Patient has a Type I hiatal hernia (defined as only the esophagogastric junction is above the diaphragm).
4. Patient has a life expectancy of less than five years making it unlikely that the subject will successfully achieve five-year follow-up.
5. Patient is a current nicotine user (including smokeless, vaporized, etc.)
6. Patient has a history of illicit drug or alcohol abuse (in the last three years).
7. Patient has an allergy to ovine-derived products or a known sensitivity to polyglycolic acid (PGA).
8. Patient has an allergy to barium.
9. Patient's surgery will include the use of an anti-reflux implantable device (LINX, etc.).
10. Patient's surgery requires the use of an additional mesh device or a pledget for reinforcement.
11. Patient has participated in another gastrointestinal (GI) clinical study within the past 30 days or is currently involved in another clinical study excluding observational and registry studies.
12. Patient had previous surgery at the gastroesophageal junction.
13. Patient had a prior hiatal hernia repair.
14. Patient has an incarcerated hernia that requires emergent intervention.
15. Patient is a prisoner.

Exclusion Criteria (Intra-operative):

1. Patient is unable to receive OviTex Core Resorbable or OviTex 1S Resorbable at time of surgery.
2. Surgery requires the use of an additional mesh device or a pledget for reinforcement.
3. Surgery includes the use of an anti-reflux implantable device (LINX, etc.).
4. Surgery performed as an open procedure.
5. Patient has a condition, which in the Investigator's opinion, may put the patient at increased risk, confound study data, or interfere significantly with the patient's participation in the study.

Where it's running

• University of South Alabama Health
  Mobile, Alabama, United States Recruiting
• SurgOne, PC
  Denver, Colorado, United States Recruiting
• University of Kentucky
  Lexington, Kentucky, United States Recruiting
• Wake Forest University Health Sciences
  Charlotte, North Carolina, United States Recruiting
• The University of Texas at Austin - Dell Medical School
  Austin, Texas, United States Recruiting

Study contacts

• Study coordinator: Melissa LaMantia, MA
• Email: mlamantia@telabio.com
• Phone: 757-761-4922

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predictors of symptom improvement after laparoscopic fundoplication

  This study tests what preoperative factors help predict which GERD patients will feel better after laparoscopic fundoplication.

  Recruiting Minia University · Minya, Minya Governorate · NCT07809620

• Comparing two surgical methods for hiatal hernia repair

  This study is testing which of two surgical methods for fixing hiatal hernias works better to prevent them from coming back and improve quality of life for patients.

  Recruiting Kuopio University Hospital · Kuopio · NCT06725433

• Using a special mesh to improve hiatal hernia surgery outcomes

  This study tests whether using a special mesh during hiatal hernia surgery can help prevent the hernia from coming back in adults with gastroesophageal reflux disease.

  Recruiting Weill Medical College of Cornell University · Los Angeles, California and 5 other locations · NCT06444347

• Comparing sutures and polyglactin mesh for hiatal hernia repair

  This study is testing whether using mesh instead of just stitches during surgery can help prevent paraesophageal hernias from coming back in patients.

  Recruiting Oulu University Hospital · Oulu · NCT05201508

• Registry for identifying risk factors of esophageal cancer

  This study is trying to find out if certain blood and tissue markers can help identify people at risk for esophageal cancer by looking at their medical history and samples.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT00260585

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.